Study of Safety, Efficacy, and Pharmacokinetics of Topical ACD440 in Healthy Volunteers

Prospective,Double-blind,Randomized,Placebo-controlled Study of Safety,Efficacy, and Pharmacokinetics of Topical ACD440 in Healthy Volunteers

Phase 1 b placebo-controlled study in healthy volunteers to study safety, efficacy and pharmacokinetics of Topical ACD440 on normal skin, skin optimized for penetration and skin exposed to ultraviolet radiation

This is an exploratory study, no primary or secondary endpoints are being defined.

Inclusion Criteria:

• Healthy volunteer
• Fitzpatrick skin type II or III
• Women not childbearing potential or highly effective contraception

Exclusion Criteria:

• Pregnancy, lactation
• Drug abuse
• Clinically significant illness
• Positive COVID 19 test at screening or COVID 19 infection in the past